Clinical Trials List
Protocol Number26866138-MMY-3002
Not yet recruiting
2005-08-01 - 2008-06-01
Phase III
Terminated2
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Ta-Chung Chao
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
680 participants
